A US-based leading generic pharmaceutical company sought Freyr's support for filing general correspondence for ANDA submissions with the USFDA. Challenges included time constraints and tracking versions of frequently changed documents for eCTD submissions.

Freyr's Publishing & Submissions team validated large volumes of documents and provided error-free submissions on time.

Download the case study to learn how Freyr helped the customer achieve Regulatory objectives in a compliant manner.